Jazz Pharmaceuticals plc - SHS USD (JAZZ)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / SHS USD
Shares, excl. options Q1 2024
56.6 M
Holdings value Q1 2024
$6.82 B
Value change Q1 2024
+$196 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
457
Number of buys Q1 2024
225
Number of sells Q1 2024
-213
Average buys Q1 2024 %
+0.004%
Average sells Q1 2024 %
-0.001%
CUSIP
G50871105
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 56.6 M $6.82 B +$196 M $120.42 457
2023 Q4 55.1 M $6.77 B -$70.2 M $123.00 482
2023 Q3 55.3 M $7.16 B -$19.7 M $129.44 471
2023 Q2 55.3 M $6.85 B -$97.9 M $123.97 456
2023 Q1 55.6 M $8.13 B -$92.8 K $146.33 454
2022 Q4 55.8 M $8.89 B -$101 M $159.31 467
2022 Q3 56.5 M $7.53 B -$94.4 M $133.29 433
2022 Q2 55.5 M $8.66 B +$138 M $156.01 434
2022 Q1 56.3 M $8.78 B -$114 M $155.67 426
2021 Q4 57.3 M $7.3 B +$28 M $127.40 415
2021 Q3 56.4 M $7.34 B -$103 M $130.21 423
2021 Q2 57 M $10.1 B +$765 M $177.64 479
2021 Q1 52.6 M $8.65 B +$71.3 M $164.37 434
2020 Q4 52.3 M $8.63 B -$303 M $165.05 415
2020 Q3 54.2 M $7.72 B +$386 M $142.59 369
2020 Q2 52 M $5.73 B +$276 M $110.34 369
2020 Q1 49.1 M $4.9 B -$262 M $99.74 386
2019 Q4 51.7 M $7.72 B +$163 M $149.28 431
2019 Q3 48.6 M $6.22 B +$107 M $128.14 393
2019 Q2 49 M $6.97 B +$348 M $142.56 399
2019 Q1 51 M $7.28 B -$214 M $142.95 409
2018 Q4 52.9 M $6.55 B -$430 M $123.96 403
2018 Q3 55 M $9.23 B -$152 M $168.13 392
2018 Q2 55.9 M $9.63 B +$535 M $172.30 370
2018 Q1 53.7 M $8.09 B -$76.3 M $150.99 318
2017 Q4 54.9 M $7.3 B -$62.5 M $134.65 312
2017 Q3 54.5 M $7.97 B +$210 M $146.25 300
2017 Q2 53 M $8.25 B +$374 M $155.50 313
2017 Q1 51.8 M $7.52 B +$546 M $145.13 298
2016 Q4 51.1 M $5.57 B -$173 M $109.03 285
2016 Q3 52.1 M $6.33 B -$32.4 M $121.48 316
2016 Q2 53.7 M $7.59 B -$46.2 M $141.31 353
2016 Q1 54.2 M $7.08 B -$237 M $130.55 328
2015 Q4 56.1 M $7.89 B -$15.9 M $140.56 335
2015 Q3 55.1 M $7.31 B +$37.4 M $132.81 347
2015 Q2 55.5 M $9.77 B +$598 M $176.07 366
2015 Q1 50.7 M $8.77 B -$334 M $172.79 353
2014 Q4 54.3 M $8.89 B +$176 M $163.73 351
2014 Q3 53.1 M $8.52 B +$372 M $160.56 323
2014 Q2 50.5 M $7.42 B +$48.4 M $147.01 304
2014 Q1 50.5 M $7 B +$311 M $138.68 313